Collagen Solutions PLC Posting of Annual Report and Notice of AGM (7870V)
July 25 2018 - 11:21AM
UK Regulatory
TIDMCOS
RNS Number : 7870V
Collagen Solutions PLC
25 July 2018
25 July 2018
Collagen Solutions plc
("Collagen Solutions" or the "Company")
Posting of Annual Report and Notice of AGM
Collagen Solutions plc (AIM: COS), the developer and
manufacturer of biomaterials and regenerative medicines for the
enhancement and extension of human life, confirms that the Annual
Report and Accounts for the year ended 31 March 2018 ('2018 Annual
Report and Accounts'), the Notice of Annual General Meeting ('AGM')
and a Form of Proxy will be posted to shareholders on 26 July 2018.
A copy of the 2018 Annual Report and Accounts will be available to
download from the Company website from that date.
The AGM will be held at 11.00am on 22 August 2018 at 3
Robroyston Oval, Nova Business Park, Glasgow G33 1AP.
For additional information on Collagen Solutions, please visit:
www.collagensolutions.com
Collagen Solutions Plc
Jamal Rushdy, CEO Via Walbrook
Hilary Spence, CFO
Lisa Baderoon, Investor Mob: 07721 413 496 or lisa.baderoon@collagensolutions.com
Relations
Cenkos Securities Plc (Nominated
Adviser and Broker)
Steve Cox (Corporate Finance) Tel: 0207 397 8900
Stephen Keys
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
Helen Cresswell Mob: 07841 917 679
About Collagen Solutions:
Collagen Solutions Plc is a global supplier, developer, and
manufacturer of medical grade collagen, tissues, and related
medical devices and components for use in regenerative medicine,
medical devices and in-vitro diagnostics and research. The Company
is also expanding its range of biomaterials-based finished medical
devices based on its internal and acquired intellectual property
for commercialisation with partners via licensing and distribution
arrangements, including ChondroMimetic(R). The Company's products
are used in a wide variety of applications including orthopaedics,
cardiovascular, dental, plastic surgery, wound healing, neurology
and urology.
For more information go to: www.collagensolutions.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCPGUMGMUPRGQA
(END) Dow Jones Newswires
July 25, 2018 12:21 ET (16:21 GMT)
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024